Article Text

Download PDFPDF

5PSQ-029 Perceived experience of patients with human immunodeficiency virus (HIV) after implementing a telepharmacy programme
  1. X Casas,
  2. A Vélez Blanco,
  3. L Ortega Valín,
  4. E Gutiérrez Gutiérrez,
  5. M Sáez Villafañe,
  6. S Llamas Lorenzana,
  7. Z Rodríguez Fernández,
  8. R Varela Fernández,
  9. JC Sáez Hortelano,
  10. J Ortiz de Urbina
  1. Complejo Asistencial Universitario de León, Farmacia, Leon, Spain


Background and Importance Telepharmacy promotes continuous and quality health care based on the use of new technologies.

Useful in patients with chronic diseases that require a pharmacovigilance programme, such as HIV patients.

Aim and Objectives To determine if a telepharmacy model, improves the perceived HIV patient experience compared to a traditional (face-to-face) model of health care.

Material and Methods Prospective observational interventional study (January to August 2022). Included 35 HIV patients with antiretroviral treatment (ART) of legal age under follow-up by the pharmacist, with access to technologies to receive telepharmacy assistance and who gave their consent.

The study was divided into 2 stages: T-4 pre-implementation of telepharmacy (January to April 2022), T+4 post-telepharmacy (May to August 2022).

Patients were recruited during the T-4 period in the pharmaceutical care office, where they were given the questionnaire: Instrument for the Evaluation of Chronic Patient eXperience (IEXPAC), a 15-item questionnaire with 11 global questions and 4 conditional questions, which makes it possible to assess the patient’s perceived experience of health care.

The SPSS®program and Wilcoxon test assessed whether there are differences in the IEXPAC (global and conditional) in the same population before and after implementing a telepharmacy programme.

Other stratification data were: sex, age, time since diagnosis and number of tablets per day.

Results 35 patients were included (100% male), median age 53 years (31-72), 97.6% took one tablet daily, median disease evolution 17 years (0.5-33).

4 telematic consultations were carried out with each patient.

Global IEXPAC: 27 patients had a better experience, 8 remained the same. Conditional IEXPAC: 30 patients had a better experience and 5 remained the same. The Wilcoxon test compared the results of IEXPAC before and after implementing a telepharmacy programme (p<0.01).

Conclusion and Relevance The implementation of telepharmacy programmes improves the experience perceived by HIV patients of pharmaceutical care.

Telepharmacy could be a useful tool for the control and pharmacotherapeutic follow-up of HIV patients and other pathologies, avoiding unnecessary trips by vulnerable patients who have difficulty in going to the hospital.

Conflict of Interest No conflict of interest

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.